AXTI — AXT, Inc., a Fremont, California-based global supplier of compound and single-element semiconductor substrates — saw its shares rocket higher by 24.76% on Friday, continuing a powerful rally sparked by the company's second-quarter 2026 earnings release. After closing Thursday's regular session at $46.94 — already up nearly 27% on the day — the stock extended its gains in Friday trading to reach $58.56. The dramatic move reflects overwhelming investor enthusiasm following quarterly results that not only shattered expectations but also included forward guidance that signals a fundamental inflection point for the business.
AXT reported second-quarter revenue of $47.6 million, a record for the company, representing a 164% surge from the $18.0 million reported in the same quarter a year ago and a 77% sequential increase from Q1 2026. The result demolished the Wall Street consensus estimate of approximately $34.1 million. Non-GAAP earnings per share came in at $0.19, an extraordinary outperformance compared to the $0.07 consensus — a beat of roughly 171% — and a dramatic turnaround from a loss of $0.15 per share in the year-ago period.
The standout performer was indium phosphide (InP), which generated record quarterly revenue of $30.7 million, driven primarily by demand for data center optical connectivity applications. Non-GAAP gross margin expanded sharply to 45.0%, up from 29.9% in the prior quarter and just 8.2% a year ago, reflecting higher volumes and a favorable product mix as the company scaled production. CEO Morris Young declared that AXT has reached "an inflection point," crediting strong customer demand and improved manufacturing productivity for a "step-function increase" in revenue.
If the Q2 results ignited the rally, the third-quarter guidance poured fuel on the fire. AXT projected Q3 non-GAAP EPS of $0.30 to $0.32 — triple the $0.10 analyst consensus — on revenue of approximately $66 million, nearly 70% above the $38.7 million Street estimate. Management noted that the $66 million figure represents revenue for which the company already holds export permits or does not require them, providing a high degree of confidence. Executives further indicated potential for "significant upside" should additional export permits be granted for other orders already backed by inventory.
The guidance reflects not just a one-time surge but what management characterized as a new, structurally higher revenue run-rate, underpinned by accelerating deployment of optical connectivity as hyperscale data center operators migrate to higher-speed transceiver modules.
Adding to the bullish narrative, AXT has secured a series of high-profile, multi-year supply agreements that bolster revenue visibility well into 2027 and beyond. On July 29, the company announced a long-term agreement with LITE — Lumentum Operations — to supply indium phosphide wafer substrates with reserved production capacity in exchange for prepayments. This followed earlier deals with COHR — Coherent Corp., which agreed to a $25.4 million prepayment — and Casela Technologies, which provided $22.3 million in upfront cash to secure capacity. Combined with an InP backlog that management described as "well over $100 million" and still growing, AXT's demand pipeline extends far beyond its current production capability.
Friday's surge occurred on exceptionally heavy volume, continuing the pattern from Thursday when more than 8.7 million shares changed hands versus a daily average of roughly 10 million. The move extended AXT's extraordinary year-to-date performance; even before this week's earnings-driven breakout, the stock had already rallied more than 150% in 2026, fueled by investor conviction that AI infrastructure spending would directly benefit upstream semiconductor material suppliers.
The broader semiconductor sector traded positively on Friday, but AXT's gains far outpaced both the SMH semiconductor ETF and the SOXX iShares Semiconductor ETF, underscoring the stock-specific nature of the catalyst. The rally pushed shares decisively above prior near-term resistance levels and through the psychologically important $50 threshold, though the stock remains well below its 52-week high of $143.16.
AXT enters the second half of 2026 with enormous tailwinds but also notable uncertainties. The company is racing to expand its indium phosphide production capacity, targeting quarterly capacity of roughly $60 million by year-end 2026 and approximately $130 million by end of 2027. Execution on these expansion plans will be critical, as demand continues to outstrip supply.
Export permit dynamics remain a key risk factor. A significant portion of AXT's revenue flows through its China-based subsidiary, and U.S.-China technology export controls introduce ongoing regulatory uncertainty. The planned shift of subsidiary Tongmei's IPO from Shanghai's STAR Market to the Hong Kong Exchange — a process expected to take approximately one year — adds another layer of complexity. Additionally, heavy insider selling in recent months, including by CEO Morris Young, may raise questions about valuation even as the fundamental story improves dramatically. Analyst opinions remain divided, with price targets ranging from $52 to $125, reflecting the wide dispersion of views on the durability of AXT's growth trajectory.
For investors seeking systematic, data-driven approaches to navigating volatile markets, Tickeron's Trending AI Robots page offers a curated selection of top-performing AI trading bots. Tickeron provides hundreds of AI-powered trading bots spanning thousands of tickers, but only those demonstrating the strongest performance under current market conditions are featured in this dynamic, regularly updated section. Bots vary by trading strategy, timeframe, performance metrics, and the symbols they trade, allowing users to identify approaches aligned with their own investment style. Explore the Trending AI Robots page to discover which automated strategies are currently leading the pack.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Moving Average Convergence Divergence (MACD) for AXTI turned positive on July 21, 2026. Looking at past instances where AXTI's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AXTI's RSI Indicator exited the oversold zone, of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Momentum Indicator moved above the 0 level on July 30, 2026. You may want to consider a long position or call options on AXTI as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where AXTI advanced for three days, in of 280 cases, the price rose further within the following month. The odds of a continued upward trend are .
AXTI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXTI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for AXTI entered a downward trend on July 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AXTI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.312) is normal, around the industry mean (8.241). AXTI has a moderately low P/E Ratio (0.000) as compared to the industry average of (79.148). AXTI's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.535). AXTI has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.006). P/S Ratio (22.676) is also within normal values, averaging (95.043).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AXTI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 67, placing this stock worse than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufactures of high-performance compound semiconductor substrates
Industry ElectronicProductionEquipment